|
Protocol Number:
77-DK-0002
- Title:
Evaluation of Patients with Thyroid Function Disorders
- Number:
77-DK-0002
- Summary:
Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas.
The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of thyroid function disorders. Many of the tests performed are in the context of standard medical care that is offered to all patients with thyroid function disorders. In addition, blood and tissue samples may be taken for research and genetic studies.
- Sponsoring Institute:
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
Yes
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
Patients of any age with known or suspected thyroid abnormalities may be included in this study. These disorders can be broadly defined as hyper- or hypothyroid states and laboratory abnormalities.
- Special Instructions:
Only a limited number of patients are being recruited at the present time. Current research aims are focusing on Graves' Dermopathy, and TSH secreting pituitary tumors.
If interested, have your health care provider send a written referral letter summarizing your thyroid disorder plus all applicable laboratory, radiology, and/or nuclear medicine reports. This information will be reviewed by Principal Investigator to determine whether you are eligible for protocol enrollment.
- Keywords:
-
Thyroid
-
Pituitary Tumors
-
Hormone Resistance
-
Hyperthyroidism
-
Hypothyroidism
-
Thyroid-Stimulating Hormone Secreting Pituitary Adenomas
-
TSH Secreting Pituitary Adenomas
-
Graves' Dermopathy
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Hyperthyroidism
-
Hypothyroidism
-
Pituitary Neoplasm
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- National Institute of Diabetes and Digestive and Kidney Diseases
- Contact(s):
-
Patient Recruitment and Public Liaison Office
Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 Electronic Mail:prpl@mail.cc.nih.gov
- Citation(s):
-
Cardiopulmonary bypass and thyroid function "A euthyroid sick syndrome"
-
Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas A follow-up of 52 patients
-
Genetic and clinical features of 42 kindreds with resistance to thyroid hormone The National Institutes of Health prospective study
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009
|
|